Abstract
Ongoing concerns about the emergence of an influenza pandemic continue as the number of avian and human infections with the H5N1 virus mount. Adequate amounts of vaccine or anti-virals are unlikely to be available early on in a pandemic, and the latter could become ineffective because of resistance. These factors have focused attention on the use of non-pharmaceutical public health interventions to inhibit human-to-human transmission.